< Back to previous page
Researcher
Katrijn Boon
- Disciplines:Microbiology not elsewhere classified
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From3 Sep 2019 → Today
Projects
1 - 1 of 1
- Development and application of NanoBRET-based technology: Unravelling signalling bias at the human chemokine receptors CXCR1 and CXCR2From3 Sep 2019 → 3 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 6 of 6
- Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular Context(2024)
Authors: Katrijn Boon, Dominique Schols, Tom Van Loy
Pages: 142 - Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization(2024)
Authors: Katrijn Boon, Dominique Schols, Tom Van Loy
- REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors(2023)
Authors: Katrijn Boon, Dominique Schols, Tom Van Loy
- Exploration of Pyrido[3,4-d]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2(2023)
Authors: Katrijn Boon, Tom Van Loy, Dominique Schols, Wim Dehaen, Steven De Jonghe
- Cellular Electrical Impedance as a Method to Decipher CCR7 Signalling and Biased Agonism(2022)
Authors: Katrijn Boon, Dominique Schols, Tom Van Loy
- Identification of novel chemotypes as CXCR2 antagonists via a scaffold hopping approach from a thiazolo[5,4-d]pyrimidine(2022)
Authors: Max Van Hoof, Katrijn Boon, Tom Van Loy, Dominique Schols, Wim Dehaen, Steven De Jonghe